Safety and Efficacy of Rechallenge With Immune Checkpoint Inhibitors in Advanced Solid Tumor: A Systematic Review and Meta-Analysis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Huijun,Xu

第一单位： Division of Life Sciences and Medicine, Department of Oncology, the First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China.

作者： Huijun,Xu ^[1] ; Yang,Yang ^[2] ; Ying,Yan ^[1] ; Mengge,Li ^[1] ; Shusheng,Wu ^[1] ; Lulu,Cao ^[1] ; Wenju,Chen ^[1] ; Huiqin,Luo ^[1] ; Yifu,He ^[1]

作者单位： Division of Life Sciences and Medicine, Department of Oncology, the First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China. ^[1] Division of Life Sciences and Medicine, Department of Ultrasound, the First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China. ^[2]

关键词 immune checkpoint inhibitors immune‐related adverse events rechallenge solid tumor

主题词人类(Humans);肿瘤(Neoplasms);老年人(Aged);男(雄)性(Male);中年人(Middle Aged);女(雌)性(Female);老年人, 80以上(Aged, 80 and over);治疗结果(Treatment Outcome);成年人(Adult);青年人(Young Adult);青少年(Adolescent)

DOI 10.1002/cam4.70324

PMID 39463070

发布时间 2024-11-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer medicine

2024年13卷20期

e70324页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Safety and Efficacy of Rechallenge With Immune Checkpoint Inhibitors in Advanced Solid Tumor: A Systematic Review and Meta-Analysis.

Cancer medicine

相似文献

Cancer medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Safety and Efficacy of Rechallenge With Immune Checkpoint Inhibitors in Advanced Solid Tumor: A Systematic Review and Meta-Analysis.

Cancer medicine

相似文献

Cancer medicine

相关期刊

检索历史清除